HDV vs IBB
iShares Core High Dividend ETF vs iShares Biotechnology ETF
- • HDV has the lower expense ratio at 0.08% vs 0.44% for IBB.
- • HDV pays a higher dividend yield (3.09%).
Side-by-side metrics
| Metric | HDV | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.08% | 0.44% |
Dividend yield Trailing 12-month yield. | 3.09% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $16.28B | $11.50B |
YTD return | 28.80% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.20 | 0.60 |
P/E ratio | 19.53 | 25.48 |
Last price | $30.57 | $217.75 |
Inception | — | — |
Issuer | iShares | iShares |
HDV top holdings
| XOM | ExxonMobil Holdings Corp | 9.62% |
| CVX | Chevron Corp | 7.27% |
| ABBV | AbbVie Inc | 6.80% |
| PG | Procter & Gamble Co | 5.40% |
| VZ | Verizon Communications Inc | 5.08% |
| PM | Philip Morris International Inc | 5.06% |
| HD | The Home Depot Inc | 4.61% |
| KO | Coca-Cola Co | 4.28% |
| PEP | PepsiCo Inc | 3.90% |
| MO | Altria Group Inc | 3.88% |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
About HDV
HDV (iShares Core High Dividend ETF) is US high-dividend stocks with quality screen. Managed by iShares, the fund carries $16.3B in assets under management, an expense ratio of 0.08%, a dividend yield of 3.09%. Its largest holding is ExxonMobil Holdings Corp (XOM), which represents 9.6% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 9.6%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.